Register entry
- Registered sites
- 1
- Active NDC listings
- 2
- Labeller names
- 2
- Live patents
- 0
- Countries
- 1
- Base
- Spain
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Justesa Imagen, S.A.U. | Avenida de San Pablo 27, Coslada, 28823, Spain (ESP) | Active ingredient (API) manufacture | 3002807366477020325 |
Catalogue
Drug listings by form and route
22 active NDC listings: 2 bulk ingredient. By marketing category: BULK INGREDIENT 2.
| Dosage form | NDCs |
|---|---|
| powder | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| justesa imagen s.a.u. | 1 |
| justesa imagen, s.a.u. | 1 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | DIATRIZOIC ACID DIHYDRATE | powder | 52134-0500BULK INGREDIENT |
| - | Iothalamic Acid | powder | 52134-0503BULK INGREDIENT |
Compare
Comparable companies in Spain
- QUIMICA SINTETICA SA1 site · 58 NDC
- Derivados Quimicos SAU1 site · 38 NDC
- INKE SA1 site · 26 NDC
- Interquim, S.A.1 site · 26 NDC
- Moehs Catalana SL1 site · 20 NDC
- ADVANCED DISPERSED PARTICLES SL.1 site · 17 NDC
- Farmhispania S.A.1 site · 17 NDC
- BCN Peptides SA1 site · 15 NDC
- Rolabo Outsourcing S.L.1 site · 9 NDC
- Union Quimico Farmaceutica SA1 site · 8 NDC
Enquiry
Common questions
- Is Justesa Imagen, S.A.U. FDA approved?
- Justesa Imagen, S.A.U. holds 1 FDA-registered establishment in Spain. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Justesa Imagen, S.A.U.'s drugs manufactured?
- The FDA register lists Coslada. Registered operations: active ingredient (API) manufacture.
- What drugs does Justesa Imagen, S.A.U. make?
- 2 products are listed under Justesa Imagen, S.A.U. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.